BrightEdge Ventures
Overview
BrightEdge is the American Cancer Society’s impact investment arm that, through equity investment seeks to translate groundbreaking cancer research into commercially accessible solutions, deepen social impact through patient first technologies, while generating financial returns that help sustain ongoing American Cancer Society research and programs in more than 5,000 local communities. Investment returns from the BrightEdge portfolio are both reinvested in the BrightEdge fund and used to sustain American Cancer Society’s life-saving programs in research, access, and health equity. BrightEdge investment decisions are made based on potential for financial return and ability to achieve mission-driven social impact.
Reach BrightEdge Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about BrightEdge Ventures
What sectors does BrightEdge Ventures invest in?
BrightEdge Ventures invests in Impact, Healthtech, Healthcare, BioTech, Pharmaceutical and Medical Devices. BrightEdge Ventures is listed as a investor in the ConnectSafely investor database.
What stage does BrightEdge Ventures invest at?
BrightEdge Ventures backs companies at Seed, Series A and Series B.
How do I contact BrightEdge Ventures?
BrightEdge Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
